Australia markets closed

Bicycle Therapeutics plc (BCYC)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
24.58-0.11 (-0.45%)
At close: 04:00PM EDT
24.28 -0.30 (-1.22%)
After hours: 04:33PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 935.84M
Enterprise value 454.37M
Trailing P/E 1.84k
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)32.43
Price/book (mrq)2.52
Enterprise value/revenue 16.84
Enterprise value/EBITDA -2.68

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 314.31%
S&P500 52-week change 322.38%
52-week high 328.91
52-week low 312.54
50-day moving average 324.01
200-day moving average 320.29

Share statistics

Avg vol (3-month) 3399.78k
Avg vol (10-day) 3328.49k
Shares outstanding 538.07M
Implied shares outstanding 636.71M
Float 8N/A
% held by insiders 11.63%
% held by institutions 1105.09%
Shares short (15 Apr 2024) 42.96M
Short ratio (15 Apr 2024) 47.04
Short % of float (15 Apr 2024) 48.58%
Short % of shares outstanding (15 Apr 2024) 47.80%
Shares short (prior month 15 Mar 2024) 42.56M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-162.40%

Management effectiveness

Return on assets (ttm)-23.04%
Return on equity (ttm)-56.13%

Income statement

Revenue (ttm)41.61M
Revenue per share (ttm)1.07
Quarterly revenue growth (yoy)298.90%
Gross profit (ttm)N/A
EBITDA -173.21M
Net income avi to common (ttm)-168.16M
Diluted EPS (ttm)-5.08
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)457M
Total cash per share (mrq)10.74
Total debt (mrq)38.85M
Total debt/equity (mrq)10.91%
Current ratio (mrq)10.42
Book value per share (mrq)8.37

Cash flow statement

Operating cash flow (ttm)-85.09M
Levered free cash flow (ttm)-46.53M